The National Center for Health Research conducts, analyzes, and explains the latest research and works with patients, consumers, and opinion leaders to use that information to improve their own health and to develop better programs, policies, and services.
- We conduct research that has the potential to improve health care.
- We translate research findings into free information and training that can be used to improve health and safety to individuals and communities nationwide.
- We work with the media to help get the word out to those who will most benefit from it.
- We educate policy makers, policy analysts, and opinion leaders through briefings, hearings, meetings, and written materials based on the information.
- We share our publications and information with other organizations, researchers, and advocates.
- We coordinate and strategize with them, working together to inform the public and be part of the public debate on policy issues.
- We use that information effectively to improve the health of adults and children.
Free Health Research 101 Teleconference has been scheduled for Wednesday, August 24, 2021 at 12 PM EST. More information will be posted shortly.
July 7, 2021, Scientific Coalition Letter on Aduhelm was sent to HHS Inspector General, CMS, Congress and the White House.
It states: “As organizations working to promote and protect science for the public good, we are writing to express our concern about the lack of scientific evidence to support the FDA’s recent accelerated approval of Biogen’s Aduhelm (aducanumab) as a drug intended to slow cognitive damage caused by Alzheimer’s disease. The next day, the FDA announced some of the changes we recommended.” Read the entire letter at http://www.center4research.org/scientific-coalition-letter-on-aduhelm-to-hhs-inspector-general/
Tuesday, June 8, 2021: NCHR president Dr. Diana Zuckerman responded to the FDA’s misguided approval of Aduhelm for Alzheimer’s Disease, despite lack of evidence that the benefits outweigh the risks.
February, 2021. The National Center for Health Research’s Insurance Coverage Assistance program for medically necessary breast implant removal is accepting new requests for assistance. For more info, visit our website here.
Are you worried you might have the coronavirus? Are you wondering if you should get the vaccine? If you’ve already had the virus or already been vaccinated, do you wonder if your life can go back to normal?
Many people who are infected don’t have any symptoms, but if you have symptoms they are likely to appear 2-14 days after exposure to the virus. Having a negative test in the first days after exposure doesn’t mean you aren’t infected. And even with a negative test, you might still be able to infect others.
Confused about the conflicting info on coronavirus face masks, testing, risks to children, and what you should and should not do? Here’s what you need to know.
News You Can Use
Breast Implant Patient Informed Consent Checklist and Black Box Warnings
This checklist and black box warning were developed by the Breast Implant Working Group, which consists of Dr. Diana Zuckerman (National Center for Health Research), Dr. Scot Glasberg (American Society of Plastic Surgeons), Dr. Alan Matarasso (also ASPS), Karuna Jaggar (Breast Cancer Action), Judy Norsigian (Our Bodies Ourselves) and breast implant patient advocates. The checklist has been endorsed by their organizations, as a requirement to be read and signed by all potential breast implant patients. As individuals, we are also urging the FDA to include a black box warning about the risks of cancer and other serious health problems for women considering breast implants.
NCHR Report: The Health Risks of MRIs with Gadolinium-Based Contrast Agents
Magnetic resonance imaging (MRI) is a common diagnostic procedure that can improve the quality of medical care and save lives. Gadolinium-based contrast agents are used with MRIs to improve diagnostic accuracy. However, in 2006, it was determined that patients with severe kidney dysfunction who underwent MRIs with contrast could develop a serious condition called nephrogenic systemic fibrosis (NSF). In recent years, there is increasing concern that gadolinium can be harmful even for patients whose kidneys are not impaired. Read this report to learn more.
NCHR Report: Is TMS Proven Effective for Depression?
Transcranial magnetic stimulation (TMS) devices have stimulated the brains of tens of thousands of patients in the U.S., often as a treatment for depression. TMS treatment typically costs $300 per session, usually 5 days/week for 4 to 6 weeks. And yet, there is no clear evidence that it works at all, or is more beneficial than the much less expensive and more convenient antidepressant medications. This report examines the questionable effectiveness of TMS, and could save you thousands of dollars and a very frustrating experience.
NCHR Report: Breast Implant Illnesses: What’s the Evidence?
Debate swirls over the risks of breast implants, and physicians and patients are justifiably confused by the conflicting information available. Despite surgeons’ claims that implants are proven safe, more than 70,000 women with breast implants have reported that they have serious symptoms that they refer to as “breast implant illness.” Our new report finds clear evidence that implants increase the chances of those symptoms and removing implants usually improves’ their health. Women considering breast implants after mastectomy or for cosmetic reasons will want to know about this report and send her a copy of this Patient Informed Consent check list!